Retour
36
Fourchette du Jour
43,01 €
47,55 €
Fourchette 52 Semaines
23,30 €
57,88 €
Volume
1 450 684
Moyenne 50J / 200J
45,44 €
/
34,84 €
Clôture Précédente
44,50 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -37,5 | 0,3 |
| P/B | 6,2 | 2,9 |
| ROE % | -16,4 | 3,7 |
| Net Margin % | -20,6 | 3,8 |
| Rev Growth 5Y % | 29,9 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
48,25 €
+1.6%
Low: 41,00 €
High: 52,00 €
BPA Prévisionnel
-1,81 €
CA Est.
440 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,25 €
1,23 € – 1,26 €
|
760 M | 2 |
| FY2029 |
0,50 €
0,49 € – 0,50 €
|
660 M | 3 |
| FY2028 |
-0,60 €
-1,32 € – 0,14 €
|
580 M | 6 |
Points Clés
Revenue grew 29,88% annually over 5 years — strong growth
Debt/Equity of 0,29 — conservative balance sheet
Negative free cash flow of -75,63M
PEG of 0,34 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,56%
Capital efficient — spends only 7,44% of revenue on capex
Croissance
Revenue Growth (5Y)
29,88%
Revenue (1Y)20,32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-16,43%
ROIC-16,75%
Net Margin-20,63%
Op. Margin-36,18%
Sécurité
Debt / Equity
0,29
Current Ratio3,64
Interest Coverage0,00
Valorisation
P/E Ratio
-37,49
P/B Ratio6,16
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,32% | Revenue Growth (3Y) | 23,95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 29,88% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 376,57M | Net Income (TTM) | -77,67M |
| ROE | -16,43% | ROA | -12,10% |
| Gross Margin | 50,72% | Operating Margin | -36,18% |
| Net Margin | -20,63% | Free Cash Flow (TTM) | -75,63M |
| ROIC | -16,75% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,29 | Current Ratio | 3,64 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -37,49 | P/B Ratio | 6,16 |
| P/S Ratio | 7,73 | PEG Ratio | 0,34 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,91B | Enterprise Value | 2,87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 376,57M | 312,97M | 245,11M | 203,57M | 132,33M |
| Net Income | -77,67M | -208,73M | -204,62M | -217,86M | -152,10M |
| EPS (Diluted) | -1,30 | -3,60 | -3,60 | -4,04 | -3,15 |
| Gross Profit | 191,00M | 133,35M | 89,73M | 84,24M | 51,71M |
| Operating Income | -136,26M | -220,83M | -217,16M | -234,78M | -152,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 641,86M | 614,32M | 776,40M | 961,38M | 702,10M |
| Total Liabilities | 168,90M | 141,63M | 152,97M | 171,99M | 121,28M |
| Shareholders' Equity | 472,96M | 472,69M | 623,43M | 789,39M | 580,82M |
| Total Debt | 137,32M | 85,03M | 94,07M | 94,91M | 62,92M |
| Cash & Equivalents | 183,05M | 226,32M | 286,47M | 378,69M | 465,83M |
| Current Assets | 332,97M | 346,78M | 424,26M | 596,48M | 546,50M |
| Current Liabilities | 91,41M | 71,01M | 73,32M | 90,66M | 63,05M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#94 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026